These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5007175)

  • 21. [Clinical use of insulin infusions using the open-loop system].
    Irsigler K; Kritz H
    Z Gesamte Inn Med; 1981 Jan; 36(1):8-19. PubMed ID: 7013294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Adsorption of insulin to the infusion equipment].
    Jervell J
    Tidsskr Nor Laegeforen; 1979 Jun; 99(17-18):899. PubMed ID: 473143
    [No Abstract]   [Full Text] [Related]  

  • 23. Heparin locks: their advantages and disadvantages.
    Thomas RB; Salter FJ
    Hosp Formul; 1975 Nov; 10(11):536-8. PubMed ID: 10237817
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro evaluation of hydraulic characteristics of prototype implantable intrathecal infusion pump.
    Nam KW; Sung MH; Kim HH; Kim KG; Kim DH; Lee BH; Jo YH
    Int J Artif Organs; 2010 Dec; 33(12):895-9. PubMed ID: 21186471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion of the Braun Unita I and perfusor to disposable syringes for continuous intravenous heparin infusion.
    Ramsay DM
    J Clin Pathol; 1972 May; 25(5):456-7. PubMed ID: 5046076
    [No Abstract]   [Full Text] [Related]  

  • 26. Insulin infusion pump.
    Holman RR; Turner RC
    Lancet; 1981 Jul; 2(8236):41. PubMed ID: 6113411
    [No Abstract]   [Full Text] [Related]  

  • 27. [Incompatibilities in infusion therapy - an overview].
    Ollenschläger G
    Infusionsther Klin Ernahr; 1983 Feb; 10(1):32-9. PubMed ID: 6404815
    [No Abstract]   [Full Text] [Related]  

  • 28. [Concerning the article "Problem of heparin dosage" by G. Mombelli].
    Krahenbuhl B
    Schweiz Med Wochenschr; 1984 Aug; 114(31-32):1102-3. PubMed ID: 6494861
    [No Abstract]   [Full Text] [Related]  

  • 29. [The treatment of diabetes mellitus using continuous subcutaneous infusion].
    van Ballegooie E; Sluiter WJ; Reitsma WD; Doorenbos H
    Ned Tijdschr Geneeskd; 1980 Nov; 124(48):2038-42. PubMed ID: 7003403
    [No Abstract]   [Full Text] [Related]  

  • 30. [Frequency analysis of the ECG at rest, during physical exercise, after administration of a glucose-insulin-potassium solution and after administration of heparin].
    Brodan V; Kolárová N; Frouz J
    Cas Lek Cesk; 1984 Feb; 123(8):225-8. PubMed ID: 6370443
    [No Abstract]   [Full Text] [Related]  

  • 31. Implantable infusion devices: gadgets for the future.
    Buchwald H; Chute EP
    Bull Am Coll Surg; 1985 May; 70(5):16-7, 24. PubMed ID: 10270918
    [No Abstract]   [Full Text] [Related]  

  • 32. Heparin lock: how, what, why.
    Huxley VD
    RN; 1979 Oct; 42(10):36-41. PubMed ID: 258496
    [No Abstract]   [Full Text] [Related]  

  • 33. Protracted parenteral drug infusion in ambulatory subjects using an implantable infusion pump.
    Rohde TD; Blackshear PJ; Varco RL; Buchwald H
    Trans Am Soc Artif Intern Organs; 1977; 23():13-6. PubMed ID: 910326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A sophisticated programmable miniaturised pump for insulin delivery.
    Klein JC; Slama G
    Med Prog Technol; 1980 Sep; 7(4):193-7. PubMed ID: 7003342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of whole blood on insulin adsorption onto intravenous infusion systems.
    Kerchner J; Colaluca DM; Juhl RP
    Am J Hosp Pharm; 1980 Oct; 37(10):1323-5. PubMed ID: 6999896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Improvement in the treatment of diabetes by means of a portable insulin-infusion apparatus. Preliminary results in 4 unstable juvenile diabetics].
    Porr O; Morell B; Walter H; Sturzenegger J; Froesch ER
    Schweiz Med Wochenschr; 1980 Nov; 110(47):1761-3. PubMed ID: 7006076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bidirectional implantable vascular access modality.
    Wigness BD; Dorman FD; Anderson MH; Rohde TD; McCarthy HB; Rupp WM; Buchwald H
    Trans Am Soc Artif Intern Organs; 1982; 28():54-7. PubMed ID: 7164297
    [No Abstract]   [Full Text] [Related]  

  • 38. Activated coagulation time test: a convenient monitor of heparinization for dogs used in cardiovascular research.
    Wilkerson RD; Conran PB; Greene SL
    Lab Anim Sci; 1984 Feb; 34(1):62-5. PubMed ID: 6716959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole-blood activated coagulation time for evaluation of heparin activity during hemodialysis: a comparison of administration by single-dose and by infusion.
    Wilhelmsson S; Lins LE
    Clin Nephrol; 1983 Feb; 19(2):82-6. PubMed ID: 6839556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hollow metal microneedles for insulin delivery to diabetic rats.
    Davis SP; Martanto W; Allen MG; Prausnitz MR
    IEEE Trans Biomed Eng; 2005 May; 52(5):909-15. PubMed ID: 15887540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.